INMUNOHISTOQUÍMICA Y LINFOMAS

[Objetivos]  [Esquemas]  [Utilidad]  [No IHQ]  [¿Linfoma B o T?]  [Subclasificación B] [Subclasificación T y NK] [Hodgkin] [¿EH clásica o PLN?] [Células dendríticas e histiocitarias][Situaciones problemáticas][Bibliografía][Lista de comprobación][Ejercicios][Iconografía][Autoevaluación]

BIBLIOGRAFÍA

  1. Algino KM, Thomason RW, King DE, et al. CD20 (pan-B cell antigen) expression on bone marrow-derived T cells. Am J Clin Pathol 1996; 106: 78-81.
  2. Álvaro Naranjo T, Bosch Príncep T, Gumà Padró J, Sanjosé S, Salvadó Usach Mt, Galcerán J, Martínez González S. Síndromes Linfoproliferativos en las comarcas de Tarragona. Estudio sobre base poblacional de Incidencia, Reclasificación y Errores Diagnósticos.  Patología. 1998;31(3):217-225.
  3. Álvaro T, Bosch R, Salvadó MT, Piris MA. True histiocytic lymphoma of the stomach associated with low-grade B-cell Mucosa Associated Lymphoma tissue (MALT)-Type lymphoma. Am J Surg Pathol 1996: 20: 1406-1411.
  4. Álvaro T; Salvadó Mt; Martínez S; Bosch R; Risa R; Barberá M. Desenmascaramiento antigénico no enzimático. Estudio comparativo entre horno microondas y olla a presión en secciones de tejido fijadas en formol e incluidas en parafina. PATOLOGÍA 1996; 29: 217-225.
  5. Álvaro-Naranjo T, Salvadó-Usach MT, Bosch-Príncep R, Martínez-González S. P53 en enfermedad de Hodking. Med  Clin (Barc) 1996; 10: 398-399.
  6. Álvaro T. Seminario sobre controversias en los linfomas llamados de tipo MALT, de zona marginal y monocitoides. En: Quinto Curso de Hematopatología. Tortosa, Inst. Cat. Salut, 1998, pp 182-208.
  7. Arber D, Weiss L. CD10: a review. Appl Immunohistochem 1997; 5: 125-140.
  8. Arber D, Weiss L. CD43: a review. Appl Immunohistochem 1993;1: 88-96.
  9. Arber D, Weiss L. CD5: a review. Appl Immunohistochem 1995; 3: 1-22.
  10. Arber D, Weiss L. CD57: a review. Appl Immunohistochem 1995; 3: 137-152.
  11. Arnulf B, Copie C, Delfau MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91: 1723-1731.
  12. Ashton-Key M, Jessup E, Isaacson PG. Immunoglobulin light chain staining in paraffin-embedded tissue using a heat mediated epitope retrieval method. Histopathology 1996;29:525-31
  13. Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma. Comparison of morphologic and immunophenotypic features. Am J surg Pathol 1999; 23: 88-96.
  14. Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998; 91: 2076-2084.
  15. Boulland ML, Kanavaros P, Wechsler J, et al. Cytotoxic protein expression in natural killer cell lymphomas and in alfabeta and gammadelta periopheral T-cell lymphomas. J Pathol 1997; 183: 432-439.
  16. Brandtzaeg P, Dale I, Gabrielsen TO. The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology 1992; 21: 191-196.
  17. Brousset P, Imadalou K, Rubie H, Delsol-Tahou M, Selves J, Robert A, Delsol G. Paraffin-section immunohistochemistry of residual disease in the testis in patients with acute lymphoblastic leukemia using anti-mb-l/CD79a (JCB117) monoclonal antibody. Appl Immunohist 1996; 4: 56-60.
  18. Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1 (Bcl-1) in mantle cell lymphoma. Enhanced staining using heat and ultrasound epitope retrieval. Appl Immunohistochem 1997; 5: 45-48.
  19. Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995; 86: 45-53.
  20. Chan JKC. Anaplastic large cell lymphoma: redifining its morphologic spectrum and importance of recognition of the ALK-positive subset. Adv Anat Pathol 1998; 5: 281-313.
  21. Chan JK, Fletcher CD, Nayler SJ, Cooper K. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997;79:294-313
  22. Chang KL, Arber DA, Weiss LM. CD20: a review. Appl Immunohistochem 1996;4:1-15.
  23. Cheson BD, Bennett JM, Grever M et al: National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
  24. Chetty R, Dada MA, Gatter KC. bcl-2: Longevity personified! Advances in Anatomic Pathology 1997; 4: 134-138.
  25. Chetty R, O´Leary JJ, Biddolph SC, Gatter KC. Immunohistochemical detection of p53 and bcl-2 proteins in Hashimoto´s thyroiditis and primary thyroid lymphomas. J Clin Pathol 1995; 48: 239-241.
  26. Chilosi M, Pizzolo G. review of terminal deoxynucleotidyl transferase. Biological aspects, methods of detection and selected diagnostic applications. Appl Immunohist 1995; 3: 209-221.
  27. Chittal S, Al Saati T, Delsol G. Epithelial membrane antigen in hematolymphoid neoplasms. A review. Appl Immunohist 1997; 5: 203-215.
  28. Chittal S, Al Saati T, Delsol G. Epithelial membrane antigen in hematolymphoid neoplasms. A review. Appl Immunohist 1997; 5: 203-215.
  29. Cibull M, Stein H, Gatter K, Masson D. The expression of the CD3 antigen in Hodgkin’s disease. Histopathology  1989;15:597-605.
  30. Delsol G, Lamant L, Mariamé B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 1997; 89, 1483-1490.
  31. Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, et al. Marginal zone B-cell lymphomas of  different sites share similar cytogenetic and morphologic features. Blood 1996; 87: 299:307.
  32. Dorfman DM, Pinkus GS. Utility of immunophenotipic studies in the diagnosis of low-grade lymphoma of MALT and other low-grade non-Hodgkin´s lymphomas of extranodal sites. Appl Immunohist 1995; 3: 160-167.
  33. Emile  JF, Boulland ML, Haioun C, et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466-1473.
  34. Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK Lymphomas") with a wide morphological spectrum. Am J Pathol 1998; 153: 875-886.
  35. Falini B, Bigerna B, Pasqualucci L, et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 1996;87:465-71
  36. Falini B, Flenghi L, Pileri S, et al . PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993;142:1359-72
  37. Felgar RE, Macon WR, Kinney MC, et al. TIA-1 expression in lymphoid neoplasms: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 1997; 150: 1893-1900.
  38. Fleming MD, Shahsafaei A, Dorfman DM. Absence of dendritic reticulum cell staining is helpful in distinguishing  T-cell-rich B-cell lymphoma from lymphocyte predominance Hodgkin´s disease. Appl Immunohist 1998; 6: 16-22.
  39. Flenghi L, Ye BH, Fizzotti M, et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol 1995; 147: 405-411.
  40. Frizzera G, Wu D, Inghirami G. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of  hematopoietic and lymphoid neoplams. Am J Clin Pathol 1999; 111 (Suppl. 1): S13-S39.
  41. Grouard G, Rissoan MC, Filgueira L, et al. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin  (IL)-3 and CD40-ligand. J Exp Med. 1997; 185: 1101-1111.
  42. Harris NL, Jaffe E, Stein H et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
  43. Harris NL. Diagnosis and classification of  lymphomas. En Colvin RB, BhanAK, McKluskey RT. Diagnostic    Immunopathology. New YorK: Raven Press, 1995:501-534.
  44. Hart DN . Dendritic cells: unique leukocyte populations which control the primary  immune response. Blood 1997;90:3245-87
  45. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245-3287.
  46. Hastrup N, Ralfkiaer E, Pallesen G. Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol 1989;42:398-402.
  47. Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on nasal and related extranodal angiocentric T/Natural Killer cell lymphomas: definitions, differentialdiagnosis, and epidemiology. Am J Surg Pathol 1996; 20: 103-111.
  48. Jaspars EH, Bloemena E, Bonnet P, et al. A new monoclonal antibody (3A5) that recognises a fixative resistant epitope on tissue macrophages and monocytes. J Clin Pathol 1994;47:248-52
  49. Kamel OW, Gelb AB, Shibuya RB, Warke RA. Leu7 (CD57) reactivity distinguishes nodular lymphocyte  predominance Hodgkin’s disease from nodular sclerosing Hodgkin’s disease, T cell rich B cell lymphoma and follicular  lymphoma. Am J Pathol 1993:142:541-6.
  50. Kaufmann O, Flath B, Spath E, et al. Immunohistochemical detection of CD5 with monoclonal antibody 4C7 on paraffin sections. Am J Clin Pathol 1997; 108: 669-673.
  51. Kitajima S, Tokunaga M, Goto M, et al. Monoclonal antibody HML-1 reactivity with adult T-cell leukaemia/lymphoma and other lymphomas. Histopathology 1994; 25: 229-236.
  52. Krenacs L, Tiszalvics L,Krenacs T, et al. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded sections with monoclonal antibody 010. J Pathol 1993; 171: 99-104.
  53. Kumar S, Green GA, Teruya J, et al. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol 1996; 9: 925-929.
  54. Kurtin PJ. How do you distinguish benign from malignant extranodal small B-cell proliferations?. Am J Clin Pathol 1999; 111 (suppl.1): S119-S126.
  55. Lasota J, Hyjek E, Koo CH, Blonski J, Miettinen M. Cytokeratin-positive large-cell lymphomas of  B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction. Am J Surg Pathol 1996;20:346-354.
  56. Malisius R, Merz H, Heinz B, et al. Constant detection of CD2, CD3, CD4, and CD5 in fixed and paraffin-embedded tissue using the peroxidase-mediated deposition of biotin-tyramide. J Histochem Cytochem 1997; 45: 1665-1672.
  57. Mason DY, Cordell JL, Brown MH et al. CD79a: a novel marker for B cell neoplasms in routinely processed tissue samples. Blood 1995; 86: 1453-1459.
  58. Mori N, Oka K, Yoda Y, et al. T-cell receptor expression in the T-cell malignancies. Am J Clin Pathol 1990; 93: 495-501.
  59. Mosialos G, et al. Circulating human dendritic cells differetially express high levels of a 55-kd actin-bundling protein. Am J Pathol 1996; 148: 593.
  60. Nguyen PL, Ferry JA, Harris NL. Progressive Transformation of germinal centers and nodular lymphocite predominance Hodgkin´s disease. A comparative immunohistochemical study.  Am J Surg Pathol 1999; 23: 27-33.
  61. Ohno F, Fukuhara S. Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leuk Lymphoma 1997; 27: 53-63.
  62. Orazi A, Jiang B, Lee C-H, English GW, Cattoretti G, Hohn K et al. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin´s disease. Am J Clin Pathol 1995; 104: 413-418.
  63. Petrella T, Dalac S, Maynadié M, et al. CD4+CD56+ cutaneous neoplasms: a distinct hematological entity?. Am J Surg Pathol 1999; 23: 137-146.
  64. Pinkus GS, Pinkus JL, Langhoff E, et al. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?. Am J Pathol 1997;150:543-62
  65. Piris MA. Patrones inmunohistológicos básicos en las proliferaciones del ganglio linfático. En: Álvaro Naranjo T. 2º Curso de Hematopatología. Tortosa: Inst Cat Salut, 1995, pp. 69-77.
  66. Piris MA, Mollejo M, Campo E, et al. A marginal zone pattern may be found in different varieties of non-Hodgkin´s lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 1998; 33: 230-239.
  67. Pittaluga S, Wiodarska I, Pulford K, Campo E, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 1997;151:343-51
  68. Ritter J, Wick M, Adesokan P et al. Assessment of clonality in cutaneous lymphoid infiltrate by polimerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol 1997; 108: 60-68.
  69. Said, JW et al. The role of follicular and interdigitating dendritic cells in HIV-related lymphoid hyperplasia: localization of fascin. Mod Pathol 1997; 10: 421.
  70. Schmidt U, Metz KA, Leder LD . T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?. Br J Haematol 1995;90:398-403
  71. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, et al. Diagnosis of t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994; 84: 3648-3652.
  72. Shipley  WR, Hammer rD, Lennington WJ,et al. Paraffin immunohistochemical detection of CD56, a useful marker for neural cell adhesion molecule (NCAM), in normal and neoplastic fixed tissues. Appl Immunohistochemistry1997; 5: 87-93.
  73. Smoller BR, Bishop K, Glusac EJ, Bhargava V, Kim YH, Warnke RA. Lymphocyte antigen abnormalities in inflammatory dermatoses. Appl Immunohist 1995; 3: 127-131.
  74. Soslow RA, Bhargava V, Warnke RA. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 1997; 28: 1158-1165.
  75. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood 1995; 85: 2654-2670.
  76. Suchi T, Lennert K, Tu L, Kikuchi M, Sato E, Stansfeld AG, Feller AC. Histopathology and immunohistochemistry of   peripheral T cell lymphomas: A proposal for their classification. J Clin Pathol 1987;40:995-1015.
  77. Suzumiya J, Ohshima K, Kikuchi M, et al. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol 1997; 182: 86-91.
  78. Swerdlow SH, Zukerberg LR, Yang WI, et al. The morphologic spectrum of non-Hodgkin´s lymphomas with BCL1/cyclin D1 gene rearrangements. Am J Surg Pathol 1996; 20: 627-640.
  79. Taylor CR, Shi SR, Cote RJ. Antigen retrieval for immunohistochemistry. Status and need for greater standardization. Appl Immunohistochem 1996; 4: 144-166.
  80. The Non-Hodgkin´s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin´s Lymphoma. Blood; 1997; 3909-3918.
  81. Thomas G, Kay EW, Nyhan B, Leader MB. VS38c shows lack of specificity as a marker of plasma cells. Appl     Immunohistochem 1997; 5: 185-188.
  82. Toccanier-Pelte MF, Skalli O, Kapanci, et al. Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am J Pathol 1987; 129: 109-118.
  83. Tsang W, Chan J. KP1 (CD68) staining of granular cell neoplasms: is KP1 a marker for lysosomes rather than the histiocytic lineage? Histopathology 1992;21:84-86.
  84. Veloso JD, Rezuke WN, Cartun RW, Abernathy EC, Pastuszak WT. Immunohistochemical distinction of follicular  lymphoma from follicular hyperplasia in formalin-fixed tissues using monoclonal antibodies MT2 and bcl-2. Appl  Immunohist 1995; 3: 153-159.
  85. von Wasielewski R, Werner M, Fischer R, et al. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997;150:793-803
  86. Warnke R, Weiss L, Chan J, et al. Classic Hodgkin´s disease. In: Tumors of the lymph nodes and spleen. Atlas of Tumor Pathology, Third Series, Fascicle 14. Washington DC. AFIP; 1995: 277-314.
  87. Warnke RA, Pulford KA, Pallesen G, et al. Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antileukocyte antibody KP1. Am J Pathol 1989;135:1089-95.
  88. Wlodarska I, De Wolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. Blood 1998; 92: 2688-95.
  89. Zarate-Osorno A, Raffeld M, Berman EL, et al. S-100 positive T-cell lymphoproliferative disorder: a case report and review of the literature. Am J Clin Pathol 1994; 102: 478-482.
  90. Zhou LJ, Tedder TF. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 1995;154:3821-35
  91. Zinzani PL, Martelli M, Magagnoli M, et al. Anaplastic large cell lymphoma Hodgkin´s-like: a randomized trial of ABVD versus MACOP-B with and without radiation theapy. Blood  1998; 92: 790-794.
  92. Zukerberg L, Collins A, Ferry J, Harris N. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin’s disease. Am J Pathol 1991;139:475-483.
     

   

flred_iz.gif (833 bytes) Volver al Índice

[Objetivos]  [Esquemas]  [Utilidad]  [No IHQ]  [¿Linfoma B o T?]  [Subclasificación B] [Subclasificación T y NK] [Hodgkin] [¿EH clásica o PLN?] [Células dendríticas e histiocitarias][Situaciones problemáticas][Bibliografía][Lista de comprobación][Ejercicios][Iconografía][Autoevaluación]